New HIV research findings from AIDS 2018 with NIH’s Dr. Carl Dieffenbach

From AIDS.gov

The first full day of sessions at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam was filled with new scientific findings shared by researchers from around the world. In a Facebook Live interview with HIV.gov, Carl Dieffenbach, Ph.D., discussed highlights of three studies presented today at the conference, including:

  • an update on a potential association between the HIV treatment medication dolutegravir and birth defects;
  • additional research on the effectiveness of HIV treatment as prevention among gay male serodifferent couples; and
  • a study on whether there may be drug-drug interactions between PrEP and feminizing hormone therapy for transgender women.

Dr. Dieffenbach is the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID).

Watch the video here.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s